impavido 10 mg
megapharm ltd - miltefosine - hard capsule - miltefosine 10 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.
impavido 10 mg
megapharm ltd - miltefosine - hard capsule - miltefosine 10 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.
impavido 50 mg
megapharm ltd - miltefosine - hard capsule - miltefosine 50 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.
impavido 50 mg
megapharm ltd - miltefosine - hard capsule - miltefosine 50 mg - miltefosine - -treatment of visceral leishmaniasis caused by leishmania donovani. -treatment of cutaneous leishmaniasis caused by leishmania brasiliensis complex or leishmania mexicana complex.
irinotecan 20 mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - 20 milligram(s)/millilitre - other antineoplastic agents; miltefosine
irinotecan 20 mg/ml concentrate for solution for infusion
fresenius kabi deutschland gmbh - irinotecan - concentrate for solution for infusion - 20 milligram(s)/millilitre - other antineoplastic agents; miltefosine